GLP-1 receptor (GLP-1R) signaling contributes to increased glucose-dependent insulin secretion, cell proliferation, islet size, portal glucose sensing, and postprandial lipid metabolism [3]
In the Standards of Medical Care in Diabetes2021, the ADA recommend that for people with indications of high risk or established CKD either a sodium-glucose co-transporter-2 inhibitor (SGLT2i) or a glucagon-like peptide-1 receptor agonist (GLP-1 RA) be considered as a treatment option, independently of metformin use [15]
SKO mice injected with liraglutide also showed a progressive normalisation of water consumption with a 45% and 62% reduction by day 12 in female and male SKO mice, respectively ( Figure 2D )
There has also been interest in using NAC to improve psychiatric conditions, but studies are mixed on whether it can help conditions such as compulsive disorders (13) (14) (55) or depression (47) (48) (49) (56)
Together, these effects can smooth our post-meal glucose levels